Additional potential mechanisms for upregulation of Bcl-3 in MM patients are gains/amplification of the BCL3 gene, as described in patients with anaplastic large cell lymphoma, or translocations involving chromosome 19, as found in patients with CLL (40, 41). The gene discussed is BCL3; the disease is anaplastic large cell lymphoma.